Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Umberto Campia, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Campia U. Vascular effects of cancer treatments. Vasc Med. 2020 06; 25(3):226-234. PMID: 32539632.
    Citations:    
  2. Campia U, Snyder J, Rizzo S, Treat-Jacobson D. Membership spotlight. Vasc Med. 2020 06; 25(3):289-291. PMID: 32393156.
    Citations:    
  3. Schinzari F, Tesauro M, Campia U, Cardillo C. Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatment. Vascul Pharmacol. 2020 May - Jun; 128-129:106676. PMID: 32224233.
    Citations:    
  4. Schinzari F, Tesauro M, Bertoli A, Valentini A, Veneziani A, Campia U, Cardillo C. Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents. Am J Physiol Endocrinol Metab. 2019 10 01; 317(4):E658-E666. PMID: 31408377.
    Citations:    
  5. Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral Artery Disease: Past, Present, and Future. Am J Med. 2019 10; 132(10):1133-1141. PMID: 31150643.
    Citations:    
  6. Campia U, Moslehi JJ, Amiri-Kordestani L, Barac A, Beckman JA, Chism DD, Cohen P, Groarke JD, Herrmann J, Reilly CM, Weintraub NL. Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association. Circulation. 2019 03 26; 139(13):e579-e602. PMID: 30786722.
    Citations:    
  7. Campia U, Gornik HL. An Interview with the SVM President. Vasc Med. 2019 02; 24(1):96-99. PMID: 30747600.
    Citations:    
  8. Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, Gardner AW, Hiatt WR, Regensteiner JG, Rich K. Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019 01 22; 139(4):e10-e33. PMID: 30586765.
    Citations:    Fields:    
  9. Zaghlol R, Kashyap K, Al-Shbool G, Basyal B, Desale S, Campia U, Barac A. Usefulness of Malignancy as a Predictor of WorseIn-Hospital Outcomes in Patients With Takotsubo Cardiomyopathy. Am J Cardiol. 2019 03 15; 123(6):995-1001. PMID: 30595393.
    Citations:    Fields:    
  10. Gourgari E, Playford MP, Campia U, Dey AK, Cogen F, Gubb-Weiser S, Mete M, Desale S, Sampson M, Taylor A, Rother KI, Remaley AT, Mehta NN. Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study. Cardiovasc Diabetol. 2018 12 19; 17(1):158. PMID: 30567548.
    Citations:    Fields:    
  11. Schmaier AA, Ambesh P, Campia U. Venous Thromboembolism and Cancer. Curr Cardiol Rep. 2018 08 20; 20(10):89. PMID: 30128839.
    Citations:    Fields:    
  12. Chopard R, Piazza G, Gale SA, Campia U, Albertsen IE, Kim J, Goldhaber SZ. Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications. Am J Med. 2018 12; 131(12):1408-1417. PMID: 30076825.
    Citations:    Fields:    
  13. Mohler ER, Campia U. Membership spotlight. Vasc Med. 2017 06; 22(3):275-277. PMID: 28494712.
    Citations:    Fields:    Translation:Humans
  14. Ambesh P, Campia U, Obiagwu C, Bansal R, Shetty V, Hollander G, Shani J. Nanomedicine in coronary artery disease. Indian Heart J. 2017 Mar - Apr; 69(2):244-251. PMID: 28460774.
    Citations: 1     Fields:    Translation:Humans
  15. Girardey M, Jesel L, Campia U, Messas N, Hess S, Imperiale A, Blondet C, Trinh A, Ohlmann P, Morel O. Impact of Malignancies in the Early and Late Time Course of Takotsubo Cardiomyopathy. Circ J. 2016 Sep 23; 80(10):2192-8. PMID: 27581345.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  16. Campia U, Barac A. Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity. Curr Treat Options Cardiovasc Med. 2016 Jul; 18(7):44. PMID: 27181399.
    Citations:    
  17. Mascali A, Franzese O, Nisticò S, Campia U, Lauro D, Cardillo C, Di Daniele N, Tesauro M. Obesity and kidney disease: Beyond the hyperfiltration. Int J Immunopathol Pharmacol. 2016 Sep; 29(3):354-63. PMID: 27044633.
    Citations: 5     Fields:    Translation:Humans
  18. Kang WY, Campia U, Didier RJ, Kiramijyan S, Koifman E, Negi SI, Lipinski MJ, Baker NC, Escarcega RO, Torguson R, Waksman R, Bernardo NL. A single center experience of Zilver PTX for femoro-popliteal lesions. Cardiovasc Revasc Med. 2016 Sep; 17(6):399-403. PMID: 27496591.
    Citations:    Fields:    Translation:Humans
  19. Kang WY, Campia U, Ota H, Didier RJ, Negi SI, Kiramijyan S, Koifman E, Baker NC, Magalhaes MA, Lipinski MJ, Escarcega RO, Torguson R, Waksman R, Bernardo NL. Vascular access in critical limb ischemia. Cardiovasc Revasc Med. 2016 Apr-May; 17(3):190-8. PMID: 27157294.
    Citations:    Fields:    Translation:Humans
  20. Kang WY, Campia U, Bernardo NL, Didier RJ, Negi SI, Kiramijyan S, Koifman E, Baker NC, Lipinski MJ, Escarcega RO, Torguson R, Waksman R. How should we manage thrombosis of Viabahn stent-graft? A case report focused on catheter-directed thrombolysis. Cardiovasc Revasc Med. 2016 Mar; 17(2):134-7. PMID: 26994746.
    Citations:    Fields:    Translation:Humans
  21. Greene SJ, Temporelli PL, Campia U, Vaduganathan M, Degli Esposti L, Buda S, Veronesi C, Butler J, Nodari S. Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction. Am J Cardiol. 2016 Feb 01; 117(3):340-6. PMID: 26708689.
    Citations: 3     Fields:    Translation:Humans
  22. Schinzari F, Iantorno M, Campia U, Mores N, Rovella V, Tesauro M, Di Daniele N, Cardillo C. Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome. Am J Physiol Endocrinol Metab. 2015 Nov 01; 309(9):E787-92. PMID: 26374766.
    Citations: 7     Fields:    Translation:Humans
  23. Brar V, Bernardo N, Suddath W, Weissman G, Asch F, Campia U. Reversal of pulmonary hypertension after percutaneous closure of congenital renal arteriovenous fistula in a 74-year old woman. Cardiovasc Revasc Med. 2015 Jul-Aug; 16(5):310-2. PMID: 26051173.
    Citations:    Fields:    Translation:Humans
  24. Brar V, Gill S, Cardillo C, Tesauro M, Panza JA, Campia U. Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men. PLoS One. 2015; 10(3):e0121810. PMID: 25807234.
    Citations: 3     Fields:    Translation:Humans
  25. Tesauro M, Nisticò S, Noce A, Tarantino A, Marrone G, Costa A, Rovella V, Di Cola G, Campia U, Lauro D, Cardillo C, Di Daniele N. The possible role of glutathione-S-transferase activity in diabetic nephropathy. Int J Immunopathol Pharmacol. 2015 Mar; 28(1):129-33. PMID: 25816416.
    Citations:    Fields:    Translation:Humans
  26. Khan SS, Campia U, Chioncel O, Zannad F, Rossignol P, Maggioni AP, Swedberg K, Konstam MA, Senni M, Nodari S, Vaduganathan M, Subacius H, Butler J, Gheorghiade M. Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial). Am J Cardiol. 2015 Mar 15; 115(6):790-6. PMID: 25728846.
    Citations: 8     Fields:    Translation:Humans
  27. Iantorno M, Campia U, Di Daniele N, Nistico S, Forleo GB, Cardillo C, Tesauro M. Gut hormones and endothelial dysfunction in patients with obesity and diabetes. Int J Immunopathol Pharmacol. 2014 Jul-Sep; 27(3):433-6. PMID: 25280035.
    Citations: 3     Fields:    Translation:Humans
  28. Menghini R, Campia U, Tesauro M, Marino A, Rovella V, Rodia G, Schinzari F, Tolusso B, di Daniele N, Federici M, Zoli A, Ferraccioli G, Cardillo C. Toll-like receptor 4 mediates endothelial cell activation through NF-?B but is not associated with endothelial dysfunction in patients with rheumatoid arthritis. PLoS One. 2014; 9(6):e99053. PMID: 24918924.
    Citations: 5     Fields:    Translation:HumansCells
  29. Campia U, Matuskey LA, Tesauro M, Cardillo C, Panza JA. PPAR? activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia. Atherosclerosis. 2014 Jun; 234(2):436-40. PMID: 24769306.
    Citations: 1     Fields:    Translation:Humans
  30. Iantorno M, Campia U, Di Daniele N, Nistico S, Forleo GB, Cardillo C, Tesauro M. Obesity, inflammation and endothelial dysfunction. J Biol Regul Homeost Agents. 2014 Apr-Jun; 28(2):169-76. PMID: 25001649.
    Citations: 29     Fields:    Translation:HumansAnimalsCells
  31. Campia U, Tesauro M, Di Daniele N, Cardillo C. The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implications. Life Sci. 2014 Nov 24; 118(2):149-55. PMID: 24607780.
    Citations: 7     Fields:    Translation:HumansAnimals
  32. Tesauro M, Iantorno M, Campia U. Obesity-related metabolic syndrome and vascular complications. Int J Endocrinol. 2013; 2013:534056. PMID: 24489541.
    Citations: 3     
  33. Gheorghiade M, Marti CN, Sabbah HN, Roessig L, Greene SJ, Böhm M, Burnett JC, Campia U, Cleland JG, Collins SP, Fonarow GC, Levy PD, Metra M, Pitt B, Ponikowski P, Sato N, Voors AA, Stasch JP, Butler J. Soluble guanylate cyclase: a potential therapeutic target for heart failure. Heart Fail Rev. 2013 Mar; 18(2):123-34. PMID: 22622468.
    Citations: 12     Fields:    Translation:HumansCells
  34. Gheorghiade M, Vaduganathan M, Ambrosy A, Böhm M, Campia U, Cleland JG, Fedele F, Fonarow GC, Maggioni AP, Mebazaa A, Mehra M, Metra M, Nodari S, Pang PS, Ponikowski P, Sabbah HN, Komajda M, Butler J. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev. 2013 Mar; 18(2):107-22. PMID: 22581217.
    Citations: 10     Fields:    Translation:Humans
  35. Nodari S, Triggiani M, Campia U, Dei Cas L. Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation. J Atr Fibrillation. 2012 Dec; 5(4):718. PMID: 28496797.
    Citations: 1     
  36. Tesauro M, Schinzari F, Adamo A, Rovella V, Martini F, Mores N, Barini A, Pitocco D, Ghirlanda G, Lauro D, Campia U, Cardillo C. Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome. Diabetes Care. 2013 Mar; 36(3):683-9. PMID: 23069838.
    Citations: 20     Fields:    Translation:Humans
  37. Schinzari F, Tesauro M, Rovella V, Di Daniele N, Gentileschi P, Mores N, Campia U, Cardillo C. Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome. Am J Physiol Endocrinol Metab. 2012 Sep 15; 303(6):E806-11. PMID: 22829585.
    Citations: 5     Fields:    Translation:Humans
  38. Campia U, Tesauro M, Cardillo C. Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque. Heart. 2012 May; 98(10):762-3. PMID: 22543836.
    Citations:    Fields:    Translation:Humans
  39. Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail. 2012 Feb; 14(2):120-9. PMID: 22253453.
    Citations: 48     Fields:    Translation:HumansAnimalsCells
  40. Campia U, Tesauro M, Cardillo C. Human obesity and endothelium-dependent responsiveness. Br J Pharmacol. 2012 Feb; 165(3):561-73. PMID: 21895631.
    Citations: 27     Fields:    Translation:HumansAnimals
  41. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L. n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation. 2011 Sep 06; 124(10):1100-6. PMID: 21844082.
    Citations: 36     Fields:    Translation:HumansPHPublic Health
  42. Blair JE, Pang PS, Schrier RW, Metra M, Traver B, Cook T, Campia U, Ambrosy A, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Konstam MA, Gheorghiade M. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011 Oct; 32(20):2563-72. PMID: 21785107.
    Citations: 28     Fields:    Translation:Humans
  43. Morel O, El Ghannudi S, Jesel L, Radulescu B, Meyer N, Wiesel ML, Caillard S, Campia U, Moulin B, Gachet C, Ohlmann P. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J Am Coll Cardiol. 2011 Jan 25; 57(4):399-408. PMID: 21251579.
    Citations: 24     Fields:    Translation:HumansCells
  44. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2011 Feb 15; 57(7):870-9. PMID: 21215550.
    Citations: 51     Fields:    Translation:HumansCTClinical Trials
  45. Campia U, Nodari S, Gheorghiade M. Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events? Curr Heart Fail Rep. 2010 Sep; 7(3):100-9. PMID: 20625945.
    Citations: 2     Fields:    Translation:HumansAnimals
  46. Campia U, Panza JA. Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes? J Am Coll Cardiol. 2008 Jun 03; 51(22):2150-2. PMID: 18510962.
    Citations: 2     Fields:    Translation:HumansAnimals
  47. Barac A, Campia U, Matuskey LA, Lu L, Panza JA. Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension. Am J Cardiol. 2008 Apr 01; 101(7):980-5. PMID: 18359318.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  48. Scuteri A, Tesauro M, Rizza S, Iantorno M, Federici M, Lauro D, Campia U, Turriziani M, Fusco A, Cocciolillo G, Lauro R. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2008 Jun; 18(5):349-56. PMID: 17935958.
    Citations: 17     Fields:    Translation:Humans
  49. Tesauro M, Rizza S, Iantorno M, Campia U, Cardillo C, Lauro D, Leo R, Turriziani M, Cocciolillo GC, Fusco A, Panza JA, Scuteri A, Federici M, Lauro R, Quon MJ. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Metabolism. 2007 Mar; 56(3):413-9. PMID: 17292732.
    Citations: 9     Fields:    Translation:Humans
  50. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertension. 2007 Apr; 49(4):748-60. PMID: 17309954.
    Citations: 30     Fields:    Translation:Humans
  51. Campia U, Matuskey LA, Panza JA. Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors. Circulation. 2006 Feb 14; 113(6):867-75. PMID: 16461819.
    Citations: 26     Fields:    Translation:HumansCells
  52. Stabile E, Kinnaird T, la Sala A, Hanson SK, Watkins C, Campia U, Shou M, Zbinden S, Fuchs S, Kornfeld H, Epstein SE, Burnett MS. CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation. 2006 Jan 03; 113(1):118-24. PMID: 16380545.
    Citations: 35     Fields:    Translation:AnimalsCells
  53. Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO, Wang Y, Katz A, Levine M, Quon MJ. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol. 2006 Jan; 290(1):H137-45. PMID: 16126809.
    Citations: 33     Fields:    Translation:Humans
  54. Campia U, Cardillo C, Panza JA. Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation. 2004 Jun 29; 109(25):3191-5. PMID: 15148269.
    Citations: 18     Fields:    Translation:Humans
  55. Cardillo C, Mettimano M, Mores N, Koh KK, Campia U, Panza JA. Plasma levels of cell adhesion molecules during hyperinsulinemia and modulation of vasoactive mediators. Vasc Med. 2004 May; 9(3):185-8. PMID: 15675182.
    Citations:    Fields:    Translation:Humans
  56. Cardillo C, Campia U, Iantorno M, Panza JA. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension. 2004 Jan; 43(1):36-40. PMID: 14656951.
    Citations: 30     Fields:    Translation:Humans
  57. Campia U, Sullivan G, Bryant MB, Waclawiw MA, Quon MJ, Panza JA. Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile. Am J Physiol Heart Circ Physiol. 2004 Jan; 286(1):H76-82. PMID: 12946932.
    Citations: 10     Fields:    Translation:Humans
  58. Cardillo C, Campia U, Bryant MB, Panza JA. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation. 2002 Oct 01; 106(14):1783-7. PMID: 12356630.
    Citations: 55     Fields:    Translation:HumansCTClinical Trials
  59. Campia U, Choucair WK, Bryant MB, Waclawiw MA, Cardillo C, Panza JA. Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans. J Am Coll Cardiol. 2002 Aug 21; 40(4):754-60. PMID: 12204507.
    Citations: 35     Fields:    Translation:Humans
  60. Campia U, Choucair WK, Bryant MB, Quyyumi AA, Cardillo C, Panza JA. Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans. Am J Cardiol. 2002 Feb 01; 89(3):286-90. PMID: 11809430.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  61. Cardillo C, Campia U, Kilcoyne CM, Bryant MB, Panza JA. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation. 2002 Jan 29; 105(4):452-6. PMID: 11815427.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  62. Moore DF, Altarescu G, Pursley R, Campia U, Panza JA, Dimitriadis E, Schiffmann R. Arterial wall properties and Womersley flow in Fabry disease. BMC Cardiovasc Disord. 2002; 2:1. PMID: 11888483.
    Citations: 6     Fields:    Translation:Humans
  63. Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, Panza JA, Schiffmann R. Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke. 2001 Jul; 32(7):1559-62. PMID: 11441201.
    Citations: 24     Fields:    Translation:Humans
  64. Mores N, Campia U, Navarra P, Cardillo C, Preziosi P. No cardiovascular effects of single-dose pseudoephedrine in patients with essential hypertension treated with beta-blockers. Eur J Clin Pharmacol. 1999 Jun; 55(4):251-4. PMID: 10424315.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  65. Cardillo C, De Felice F, Campia U, Musumeci V, Folli G. Relation of stress testing and ambulatory blood pressure to hypertensive cardiac damage. Am J Hypertens. 1996 Feb; 9(2):162-70. PMID: 8924266.
    Citations: 1     Fields:    Translation:Humans
  66. Musumice V, Di Salvo S, Campia U, Cardillo C. Postprandial Hemodynamic Changes in Hypertensives Treated with Calcium Antagonists or ACE Inhibitors. Am J Ther. 1995 Mar; 2(3):170-174. PMID: 11847548.
    Citations:    Fields:    
  67. Cardillo C, Mores N, Campia U, Musumeci V, Motolese M, Folli G. Effects of the Calcium Antagonist Felodipine on Resting and Stress Testing Blood Pressure in Essential Hypertension. Am J Ther. 1994 Oct; 1(3):198-205. PMID: 11835087.
    Citations:    Fields:    
  68. Cardillo C, De Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension. 1993 Jun; 21(6 Pt 1):836-44. PMID: 8500864.
    Citations: 10     Fields:    Translation:Humans
  69. Cardillo C, Degen C, Campia U, De Felice F, Folli G. Comparison of the effects of terazosin and enalapril on laboratory stress testing blood pressure in patients with essential hypertension. J Clin Pharmacol. 1993 May; 33(5):433-8. PMID: 8101194.
    Citations:    Fields:    Translation:HumansCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Campia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (322)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.